Found: 24
Select item for more details and to access through your institution.
The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1623, doi. 10.1038/leu.2015.113
- By:
- Publication type:
- Article
Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1798, doi. 10.1038/leu.2015.178
- By:
- Publication type:
- Article
A coiled-coil mimetic intercepts BCR-ABL1 dimerization in native and kinase-mutant chronic myeloid leukemia.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1668, doi. 10.1038/leu.2015.53
- By:
- Publication type:
- Article
Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knock-in mice.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1771, doi. 10.1038/leu.2015.58
- By:
- Publication type:
- Article
The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myeloma.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1713, doi. 10.1038/leu.2015.65
- By:
- Publication type:
- Article
Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1702, doi. 10.1038/leu.2015.99
- By:
- Publication type:
- Article
Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1721, doi. 10.1038/leu.2015.80
- By:
- Publication type:
- Article
Low platelet count reduces subsequent complete remission rate despite marrow with <5% blasts after AML induction therapy.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1779, doi. 10.1038/leu.2015.23
- By:
- Publication type:
- Article
Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1754, doi. 10.1038/leu.2015.75
- By:
- Publication type:
- Article
Characterisation of a compound in-cis GATA2 germline mutation in a pedigree presenting with myelodysplastic syndrome/acute myeloid leukemia with concurrent thrombocytopenia.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1795, doi. 10.1038/leu.2015.40
- By:
- Publication type:
- Article
Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1695, doi. 10.1038/leu.2015.60
- By:
- Publication type:
- Article
The Notch ligand DLL4 specifically marks human hematoendothelial progenitors and regulates their hematopoietic fate.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1741, doi. 10.1038/leu.2015.74
- By:
- Publication type:
- Article
The diagnostic gray zone between Burkitt lymphoma and diffuse large B-cell lymphoma is also a gray zone of the mutational spectrum.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1789, doi. 10.1038/leu.2015.34
- By:
- Publication type:
- Article
KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1656, doi. 10.1038/leu.2015.107
- By:
- Publication type:
- Article
F604S exchange in FIP1L1-PDGFRA enhances FIP1L1-PDGFRA protein stability via SHP-2 and SRC: a novel mode of kinase inhibitor resistance.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1763, doi. 10.1038/leu.2015.70
- By:
- Publication type:
- Article
CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1637, doi. 10.1038/leu.2015.52
- By:
- Publication type:
- Article
The DEK oncoprotein and its emerging roles in gene regulation.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1632, doi. 10.1038/leu.2015.72
- By:
- Publication type:
- Article
Blocking programmed cell death 1 in combination with adoptive cytotoxic T-cell transfer eradicates chronic myelogenous leukemia stem cells.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1781, doi. 10.1038/leu.2015.26
- By:
- Publication type:
- Article
Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1676, doi. 10.1038/leu.2015.50
- By:
- Publication type:
- Article
Ponatinib is not transported by ABCB1, ABCG2 or OCT-1 in CML cells.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1792, doi. 10.1038/leu.2015.35
- By:
- Publication type:
- Article
Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1648, doi. 10.1038/leu.2015.59
- By:
- Publication type:
- Article
AML1/ETO cooperates with HIF1α to promote leukemogenesis through DNMT3a transactivation.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1730, doi. 10.1038/leu.2015.56
- By:
- Publication type:
- Article
IL10 receptor is a novel therapeutic target in DLBCLs.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1684, doi. 10.1038/leu.2015.57
- By:
- Publication type:
- Article
Cellular origin of prognostic chromosomal aberrations in AML patients.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 8, p. 1785, doi. 10.1038/leu.2015.30
- By:
- Publication type:
- Article